Patent · US Active

Therapeutic peptides

US11607443B2 · kind B2 · utility

0Cited by

1References

9Claims

0Family size

Assignees

UNIVERSITE TOULOUSE III—PAUL SABATIER · FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) · FR
ETABLISSEMENT FRANCAIS DU SANG (EFS) · FR

Inventors

Jean-Philippe COMBIER · Ramonville-Saint-Agne, FR
Anne PREL · Toulouse, FR
Frédéric DESCHASEAUX · Toulouse, FR

Key dates

Filing date	Dec 22, 2017
Grant date	Mar 21, 2023
Priority date	—
Expiry date	May 14, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/178
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions containing micropeptides capable of modulating the accumulation of miRs involved in certain pathologies, and the use of these micropeptides for treating the certain pathologies. Also, methods of identifying these micropeptides modulating the accumulation of miRs involved in pathologies. Further, nuclei acids encoding those micropeptides that modulate the accumulation of miRs involved in pathologies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.